Cindy Lynch, J.D. has assumed the position of vice president, general counsel at Simplify Medical Pty Ltd, based in the San Francisco Bay area. Lynch has nearly 15 years of experience providing strategic legal and intellectual property advice to medical device startups. Simplify Medical is the manufacturer of the Simplify cervical artificial disc.
Cindy Lynch: New VP, General Counsel at Simplify Medical
1 min read Premium comments
Secondary#simplifymedical#cindylynch
David Hovda, chief executive officer of Simplify Medical, commented, “Cindy has led our intellectual property program for years, and we are very excited she has joined our team as General Counsel. While continuing to lead our IP program, which we believe is the largest and most impactful portfolio in cervical spine motion preservation, she will lead our overall legal strategy and continue to ensure our technology remains fully protected.”
According to the company, “Lynch specializes in intellectual property law and business venture advising. Prior to consulting for companies including Simplify Medical as in-house Counsel, she worked as the VP of Intellectual Property at Elixir Medical Corporation, Moximed, Inc., SpinalMotion, Inc., Conor Medsystems, Inc., and as a partner at Burns, Doane, Swecker & Mathis, LLP. Lynch will complete her M.B.A. from San Francisco State University in 2018 and earned her J.D. from George Mason University School of Law in 1995.”
“I am thrilled to be part of the Simplify Medical team,” Lynch said. “This is an exciting time to be working with Simplify as we near completion of the two-level Simplify Disc IDE [investigational device exemption] trial enrollment and work toward the highly-anticipated commercial launch of the Simplify Disc, which will provide patients an innovative option for cervical disc replacement. As we continue to expand our commercial efforts, the protection of Simplify’s legal and IP [intellectual property] interests is critical, and I look forward to working closely with the management team in these efforts.”
Lynch told OTW, “Simplify continues to be active in generating new IP for next generation cervical disc products and for some other exciting new spine projects.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.